These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27235189)

  • 1. Antimicrobial peptides as novel anti-tuberculosis therapeutics.
    Silva JP; Appelberg R; Gama FM
    Biotechnol Adv; 2016; 34(5):924-940. PubMed ID: 27235189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects.
    Padhi A; Sengupta M; Sengupta S; Roehm KH; Sonawane A
    Tuberculosis (Edinb); 2014 Jul; 94(4):363-73. PubMed ID: 24813349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment.
    Silva JP; Gonçalves C; Costa C; Sousa J; Silva-Gomes R; Castro AG; Pedrosa J; Appelberg R; Gama FM
    J Control Release; 2016 Aug; 235():112-124. PubMed ID: 27261333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between antimicrobial peptides and mycobacteria.
    Gutsmann T
    Biochim Biophys Acta; 2016 May; 1858(5):1034-43. PubMed ID: 26851776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial peptides as an alternative to anti-tuberculosis drugs.
    AlMatar M; Makky EA; Yakıcı G; Var I; Kayar B; Köksal F
    Pharmacol Res; 2018 Feb; 128():288-305. PubMed ID: 29079429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-mycobacterial peptides: from human to phage.
    Teng T; Liu J; Wei H
    Cell Physiol Biochem; 2015; 35(2):452-66. PubMed ID: 25613372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Peptides: A Promising Strategy for Anti-tuberculosis Therapeutics.
    Ning Y; Wang L; Wang M; Meng X; Qiao J
    Protein Pept Lett; 2023; 30(4):280-294. PubMed ID: 36924097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review on anti-tuberculosis peptides: Impact of peptide structure on anti-tuberculosis activity.
    Yathursan S; Wiles S; Read H; Sarojini V
    J Pept Sci; 2019 Nov; 25(11):e3213. PubMed ID: 31515916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates.
    Portell-Buj E; Vergara A; Alejo I; López-Gavín A; Monté MR; San Nicolás L; González-Martín J; Tudó G
    J Med Microbiol; 2019 Feb; 68(2):211-215. PubMed ID: 30570475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin.
    Khara JS; Wang Y; Ke XY; Liu S; Newton SM; Langford PR; Yang YY; Ee PL
    Biomaterials; 2014 Feb; 35(6):2032-8. PubMed ID: 24314557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Peptides as Immunomodulators and Antimycobacterial Agents to Combat Mycobacterium tuberculosis: a Critical Review.
    R PA; Anbarasu A
    Probiotics Antimicrob Proteins; 2023 Dec; 15(6):1539-1566. PubMed ID: 36576687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial peptides for the treatment of pulmonary tuberculosis, allies or foes?
    Rivas-Santiago B; Torres-Juarez F
    Curr Pharm Des; 2018; 24(10):1138-1147. PubMed ID: 29589538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis.
    Kwok PC; Grabarek A; Chow MY; Lan Y; Li JC; Casettari L; Mason AJ; Lam JK
    Int J Pharm; 2015 Aug; 491(1-2):367-74. PubMed ID: 26151107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antimicrobial peptides in host defense against mycobacterial infections.
    Méndez-Samperio P
    Peptides; 2008 Oct; 29(10):1836-41. PubMed ID: 18582513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
    Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
    Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B1CTcu5: A frog-derived brevinin-1 peptide with anti-tuberculosis activity.
    Abraham P; Jose L; Maliekal TT; Kumar RA; Kumar KS
    Peptides; 2020 Oct; 132():170373. PubMed ID: 32679168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taming the Devil: Antimicrobial Peptides for Safer TB Therapeutics.
    Jadhav K; Singh R; Ray E; Singh AK; Verma RK
    Curr Protein Pept Sci; 2022; 23(10):643-656. PubMed ID: 35619262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tachyplesin and CyLoP-1 as efficient anti-mycobacterial peptides: A novel finding.
    Priya A; Aditya A; Budagavi DP; Chugh A
    Biochim Biophys Acta Biomembr; 2022 Jul; 1864(7):183895. PubMed ID: 35271828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.